Singapore biotech firm hopes for ‘widespread’ release of new Covid-19 treatment by early 2021

A new Covid-19 treatment could become available in Singapore and beyond by early 2021 as homegrown biotech company Hummingbird Bioscience joins major names in making steps to combat the coronavirus